ArticleWorld journal of clinical cases2025
Mucocutaneous manifestation mimicking vasculitis in chronic hepatitis B: A case report.
Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B virus (HBV) primarily causes hepatic inflammation and has various clinical manifestations. However, extrahepatic reactions, ranging from localized or systemic inflammation, may occur in some cases. Here, we report a case of an acute exacerbation of chronic HBV infection with atypical extrahepatic manifestation confined to the skin and mucosa despite nucleotide analog treatment, which was fully recovered on systemic steroid treatment. CASE SUMMARY: A 53-year-old woman visited a clinic due to worsening skin rash and mucosal inflammation. She was receiving antiviral therapy due to a recent acute exacerbation of chronic HBV infection. While liver function was improving with antiviral treatment, skin rash and mucosal inflammatory lesions gradually worsened. Thus, blood tests and skin biopsy were performed to determine the cause. Despite a thorough review of serum markers and skin biopsy results, a concrete diagnosis revealing other etiology apart from the acute phase of HBV infection could not be established. The cutaneous lesions were considered a rare immunologic extrahepatic manifestation of HBV, warranting systemic steroid treatment. Afterward, both skin and mucosal lesions rapidly improved, and the patient was discharged without any sequelae.
conclusionClinicians should recognize mucocutaneous manifestations of chronic HBV, as systemic steroids may yield favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.